Clinical trial
Clindamycin as Antimicrobial Treatment for Streptococcus Spp. PeRiprosthetic Infection
NCT07335627 is registered in ClinicalTrials.gov with University Hospital, Strasbourg, France as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clindamycin as Antimicrobial Treatment for Streptococcus Spp. PeRiprosthetic Infection
- Lead sponsor
- University Hospital, Strasbourg, France
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- February 21, 2025
- Completion date
- July 21, 2026
- Enrollment
- 260 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
streptococcus infection